» Articles » PMID: 37498686

Human Immune Phenotyping Reveals Accelerated Aging in Type 1 Diabetes

Abstract

The proportions and phenotypes of immune cell subsets in peripheral blood undergo continual and dramatic remodeling throughout the human life span, which complicates efforts to identify disease-associated immune signatures in type 1 diabetes (T1D). We conducted cross-sectional flow cytometric immune profiling on peripheral blood from 826 individuals (stage 3 T1D, their first-degree relatives, those with ≥2 islet autoantibodies, and autoantibody-negative unaffected controls). We constructed an immune age predictive model in unaffected participants and observed accelerated immune aging in T1D. We used generalized additive models for location, shape, and scale to obtain age-corrected data for flow cytometry and complete blood count readouts, which can be visualized in our interactive portal (ImmScape); 46 parameters were significantly associated with age only, 25 with T1D only, and 23 with both age and T1D. Phenotypes associated with accelerated immunological aging in T1D included increased CXCR3+ and programmed cell death 1-positive (PD-1+) frequencies in naive and memory T cell subsets, despite reduced PD-1 expression levels on memory T cells. Phenotypes associated with T1D after age correction were predictive of T1D status. Our findings demonstrate advanced immune aging in T1D and highlight disease-associated phenotypes for biomarker monitoring and therapeutic interventions.

Citing Articles

Serological markers of exocrine pancreatic function are differentially informative for distinguishing individuals progressing to type 1 diabetes.

Williams M, Grace C, Posgai A, McGrail K, Brusko M, Haller M BMJ Open Diabetes Res Care. 2025; 13(1.

PMID: 39755561 PMC: 11749058. DOI: 10.1136/bmjdrc-2024-004655.


Interleukin-1 receptor-dependent and -independent caspase-1 activity in retinal cells mediated by receptor interacting protein 2.

Coughlin B, Christian B, Trombley B, Mohr S Front Cell Dev Biol. 2024; 12:1467799.

PMID: 39483336 PMC: 11525982. DOI: 10.3389/fcell.2024.1467799.


Autoimmune CD4 T cells fine-tune TCF1 expression to maintain function and survive persistent antigen exposure during diabetes.

Aljobaily N, Allard D, Perkins B, Raugh A, Galland T, Jing Y Immunity. 2024; 57(11):2583-2596.e6.

PMID: 39396521 PMC: 11563894. DOI: 10.1016/j.immuni.2024.09.016.


Immune perturbations in human pancreas lymphatic tissues prior to and after type 1 diabetes onset.

Golden G, Wu V, Hamilton J, Amses K, Shapiro M, Japp A bioRxiv. 2024; .

PMID: 39345402 PMC: 11429609. DOI: 10.1101/2024.04.23.590798.


Low-level HIV-1 viremia affects T-cell activation and senescence in long-term treated adults in the INSTI era.

Lara-Aguilar V, Llamas-Adan M, Brochado-Kith O, Crespo-Bermejo C, Grande-Garcia S, Arca-Lafuente S J Biomed Sci. 2024; 31(1):80.

PMID: 39160510 PMC: 11334306. DOI: 10.1186/s12929-024-01064-z.


References
1.
Carey I, Critchley J, DeWilde S, Harris T, Hosking F, Cook D . Risk of Infection in Type 1 and Type 2 Diabetes Compared With the General Population: A Matched Cohort Study. Diabetes Care. 2018; 41(3):513-521. DOI: 10.2337/dc17-2131. View

2.
Insel R, Dunne J, Atkinson M, Chiang J, Dabelea D, Gottlieb P . Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care. 2015; 38(10):1964-74. PMC: 5321245. DOI: 10.2337/dc15-1419. View

3.
Williams M, Bacher R, Perry D, Grace C, McGrail K, Posgai A . Genetic Composition and Autoantibody Titers Model the Probability of Detecting C-Peptide Following Type 1 Diabetes Diagnosis. Diabetes. 2021; 70(4):932-943. PMC: 7980194. DOI: 10.2337/db20-0937. View

4.
Frasca D, Landin A, Lechner S, Ryan J, Schwartz R, Riley R . Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J Immunol. 2008; 180(8):5283-90. DOI: 10.4049/jimmunol.180.8.5283. View

5.
Hao Z, Lin M, Du F, Xin Z, Wu D, Yu Q . Systemic Immune Dysregulation Correlates With Clinical Features of Early Non-Small Cell Lung Cancer. Front Immunol. 2022; 12:754138. PMC: 8804248. DOI: 10.3389/fimmu.2021.754138. View